ACTN4 and breast carcinoma: For instance, ellagic acid disrupts the ACTN4 interaction with β-catenin, which subsequently leads to the suppression of breast cancer cell proliferation as well as ablating tumor growth and metastasis in an MMTV-PyMT breast cancer mouse model [35].